286 related articles for article (PubMed ID: 28114930)
1. Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT).
Zarrabeitia R; Fariñas-Álvarez C; Santibáñez M; Señaris B; Fontalba A; Botella LM; Parra JA
Health Qual Life Outcomes; 2017 Jan; 15(1):19. PubMed ID: 28114930
[TBL] [Abstract][Full Text] [Related]
2. The effects of epistaxis on health-related quality of life in patients with hereditary hemorrhagic telangiectasia.
Merlo CA; Yin LX; Hoag JB; Mitchell SE; Reh DD
Int Forum Allergy Rhinol; 2014 Nov; 4(11):921-5. PubMed ID: 25145809
[TBL] [Abstract][Full Text] [Related]
3. Intranasal bevacizumab injections improve quality of life in HHT patients.
Steineger J; Geirdal AØ; Osnes T; Heimdal KR; Dheyauldeen S
Laryngoscope; 2020 May; 130(5):E284-E288. PubMed ID: 31287573
[TBL] [Abstract][Full Text] [Related]
4. The natural history of epistaxis in patients with hereditary hemorrhagic telangiectasia in the Norwegian population: a cross-sectional study.
Dheyauldeen S; Abdelnoor M; Bachmann-Harildstad G
Am J Rhinol Allergy; 2011; 25(4):214-8. PubMed ID: 21819756
[TBL] [Abstract][Full Text] [Related]
5. Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: a double-blind, randomized, placebo-controlled trial.
Riss D; Burian M; Wolf A; Kranebitter V; Kaider A; Arnoldner C
Head Neck; 2015 Jun; 37(6):783-7. PubMed ID: 24595923
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis: A Randomized Clinical Trial.
Peterson AM; Lee JJ; Kallogjeri D; Schneider JS; Chakinala MM; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1006-1014. PubMed ID: 32940653
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of the severity and progression of epistaxis in hereditary hemorrhagic telangiectasia 1 versus hereditary hemorrhagic telangiectasia 2.
Hunter BN; Timmins BH; McDonald J; Whitehead KJ; Ward PD; Wilson KF
Laryngoscope; 2016 Apr; 126(4):786-90. PubMed ID: 26372311
[TBL] [Abstract][Full Text] [Related]
8. The minimal important difference of the epistaxis severity score in hereditary hemorrhagic telangiectasia.
Yin LX; Reh DD; Hoag JB; Mitchell SE; Mathai SC; Robinson GM; Merlo CA
Laryngoscope; 2016 May; 126(5):1029-32. PubMed ID: 26393959
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of the Nasal Outcome Score for Epistaxis in Hereditary Hemorrhagic Telangiectasia (NOSE HHT).
Peterson AM; Kallogjeri D; Spitznagel E; Chakinala MM; Schneider JS; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):999-1005. PubMed ID: 33022056
[TBL] [Abstract][Full Text] [Related]
10. Sinonasal quality of life outcomes following laser treatment of epistaxis related to hereditary hemorrhagic telangiectasia.
Kuan EC; Peng KA; Thompson CF; Suh JD; Wang MB
Lasers Med Sci; 2017 Apr; 32(3):527-531. PubMed ID: 28116537
[TBL] [Abstract][Full Text] [Related]
11. Epistaxis in children and adolescents with hereditary hemorrhagic telangiectasia.
Gonzalez CD; Mcdonald J; Stevenson DA; Whitehead KJ; Petersen MG; Presson AP; Ding Q; Wilson KF
Laryngoscope; 2018 Jul; 128(7):1714-1719. PubMed ID: 29171658
[TBL] [Abstract][Full Text] [Related]
12. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial.
Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR
JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329
[TBL] [Abstract][Full Text] [Related]
13. Improvement in epistaxis management: the experience of a dedicated hereditary haemorrhagic telangiectasia clinic.
Anning R; Huang J; Ronan A; de Malmanche J; Asher R; Low TH
ANZ J Surg; 2022 Mar; 92(3):499-504. PubMed ID: 34724318
[TBL] [Abstract][Full Text] [Related]
14. Sclerotherapy and Topical Nasal Propranolol: An Effective and Safe Therapy for HHT-Epistaxis.
Esteban-Casado S; Martín de Rosales Cabrera AM; Usarralde Pérez A; Martínez Simón JJ; Zhan Zhou E; Marcos Salazar MS; Pérez Encinas M; Botella Cubells L
Laryngoscope; 2019 Oct; 129(10):2216-2223. PubMed ID: 30908653
[TBL] [Abstract][Full Text] [Related]
15. Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients.
Pagella F; Colombo A; Matti E; Giourgos G; Tinelli C; Olivieri C; Danesino C
Am J Rhinol Allergy; 2009; 23(1):52-8. PubMed ID: 19379613
[TBL] [Abstract][Full Text] [Related]
16. TIMolol nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia (HHT) - Study protocol of the prospective, randomized, double-blind, controlled cross-over TIM-HHT trial.
Andorfer KEC; Seebauer CT; Koller M; Zeman F; Berneburg M; Fischer R; Vielsmeier V; Bohr C; Kühnel TS
Clin Hemorheol Microcirc; 2022; 80(3):307-315. PubMed ID: 34864649
[TBL] [Abstract][Full Text] [Related]
17. Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire.
Karapantzos I; Tsimpiris N; Goulis DG; Van Hoecke H; Van Cauwenberge P; Danielides V
Eur Arch Otorhinolaryngol; 2005 Oct; 262(10):830-3. PubMed ID: 15739086
[TBL] [Abstract][Full Text] [Related]
18. Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT).
Lee JM; Wu V; Faughnan ME; Lasso A; Figol A; Kilty SJ
J Otolaryngol Head Neck Surg; 2019 Oct; 48(1):48. PubMed ID: 31615556
[TBL] [Abstract][Full Text] [Related]
19. Development and performance of a hereditary hemorrhagic telangiectasia-specific quality-of-life instrument.
Kasthuri RS; Chaturvedi S; Thomas S; Vandergrift N; Bann C; Schaefer N; Clancy MS; Pyeritz R; McCrae KR
Blood Adv; 2022 Jul; 6(14):4301-4309. PubMed ID: 35877137
[TBL] [Abstract][Full Text] [Related]
20. Laser-Assisted Control of Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review.
Abiri A; Goshtasbi K; Maducdoc M; Sahyouni R; Wang MB; Kuan EC
Lasers Surg Med; 2020 Apr; 52(4):293-300. PubMed ID: 31441079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
